OTCMCGNSF
Market cap291kUSD
Dec 23, Last price
0.00USD
1D
-14.47%
1Q
-62.64%
IPO
-99.07%
Name
Cognetivity Neurosciences Ltd
Chart & Performance
Profile
Cognetivity Neurosciences Ltd. operates as a healthcare company. It develops an integrated cognitive assessment, a cognitive testing platform for use in medical, commercial, and consumer environments that helps to detect the earliest signs of impairment by testing the performance of large areas of the brain to support the diagnosis of dementia; and offers OptiMind, a wellness app. The company was formerly known as Utor Capital Corp. and changed its name to Cognetivity Neurosciences Ltd. in December 2017. Cognetivity Neurosciences Ltd. was incorporated in 2015 and is headquartered in Vancouver, Canada.
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|
2023‑01 | 2022‑01 | 2021‑01 | 2020‑01 | 2019‑01 | 2018‑01 | 2017‑01 | 2016‑01 | |
Income | ||||||||
Revenues | 45 | |||||||
Cost of revenue | 8,391 | 12,984 | ||||||
Unusual Expense (Income) | ||||||||
NOPBT | (8,346) | (12,984) | ||||||
NOPBT Margin | ||||||||
Operating Taxes | 82 | |||||||
Tax Rate | ||||||||
NOPAT | (8,346) | (13,065) | ||||||
Net income | (7,434) -43.37% | (13,127) 580.84% | ||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | 2,633 | 1,274 | ||||||
BB yield | ||||||||
Debt | ||||||||
Debt current | 2,533 | 1,295 | ||||||
Long-term debt | ||||||||
Deferred revenue | ||||||||
Other long-term liabilities | 2,125 | 2,125 | ||||||
Net debt | 289 | (82) | ||||||
Cash flow | ||||||||
Cash from operating activities | (5,942) | (3,215) | ||||||
CAPEX | (23) | (100) | ||||||
Cash from investing activities | (70) | (100) | ||||||
Cash from financing activities | 6,879 | 3,332 | ||||||
FCF | (3,873) | (10,680) | ||||||
Balance | ||||||||
Cash | 2,244 | 1,377 | ||||||
Long term investments | ||||||||
Excess cash | 2,242 | 1,377 | ||||||
Stockholders' equity | (4,703) | (5,675) | ||||||
Invested Capital | (1,771) | 3,420 | ||||||
ROIC | ||||||||
ROCE | 128.91% | 575.58% | ||||||
EV | ||||||||
Common stock shares outstanding | 85,049 | 73,057 | ||||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | (8,321) | (12,959) | ||||||
EV/EBITDA | ||||||||
Interest | 1,027 | 61 | ||||||
Interest/NOPBT |